case_images: PMC9493459_01
case_images: The patient on acupuncture. (1) The main acupoints for the patient, bilateral Zusanli [ST 36, (A)], Sanyinjiao [SP 6, (B)], Taixi [KI 3, (B)], Yongquan [KI 1, (C)], Bafeng [EX-LE10, (D)]. SP 6 and KI 3 were connected to electroacupuncture equipment for 30 min. (2) Brownish skin pigmentation and chapped skin due to prolonged use of clofazimine were observed.
case_images: fneur-13-985499-g0001.jpg
case_images: PMC9493459_01_fneur-13-985499-g0001.jpg
case_images: F1
case_images: Subsequently, the acupuncturist used the Bilateral Zusanli (ST 36), Sanyinjiao (SP 6), Taixi (KI 3), Yongquan (KI 1), and Bafeng (EX-LE10) points (Figure 1). After the insertion, the needles were manipulated to achieve Deqi, and the needles at SP 6 and KI 3 were connected to electroacupuncture equipment for 30 min, as shown in Figure 1.
case_images: SF-MPQ Trend Chart. The evaluation process: (A) From 10-Oct-2021 to 29-Oct-2021, hospitalized and treated with electro-acupuncture+TCM fumigation. (B) 12-Nov 2021, return visit 2 weeks after discharge, TCM fumigated at home. (C) From 2 Dec 2021 to 15 Dec 2021, hospitalized but without acupuncture treatment. (D) From 9 Feb-2022 to 18 Feb-2022, hospitalized and treated again with electro-acupuncture+TCM fumigation.
case_images: fneur-13-985499-g0002.jpg
case_images: PMC9493459_01_fneur-13-985499-g0002.jpg
case_images: F2
case_images: There were significant changes in the scores of the SF-MPQ (PRI decreased from 19 to 7, VAS decreased from 9 to 4, and PPI decreased from 5 to 2; Figure 2). The patient's lower limb pain and other symptoms were not significantly relieved, and he could not tolerate linezolid anymore; therefore, it was discontinued. Trends in pain assessment over the course of treatment are shown in Figure 2.